Breast cancer screening in women surviving Hodgkin disease

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 3, 2006, Pages 258-266

  Bloom, Joan R ^a   Stewart, Susan L ^b   Hancock, Steven L ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer risk; Breast cancer screening; Hodgkin disease; Intervention; Late effects of treatment

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT COUNSELING; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TELEPHONE; BREAST TUMOR; COUNSELING; HEALTH BEHAVIOR; INTERVENTION STUDY; ONSET AGE; PATIENT EDUCATION; RADIATION INJURY; RADIOGRAPHY; RISK FACTOR; SURVIVOR;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; COUNSELING; FEMALE; HEALTH BEHAVIOR; HODGKIN DISEASE; HUMANS; INTERVENTION STUDIES; MAMMOGRAPHY; NEOPLASMS, RADIATION-INDUCED; PATIENT EDUCATION; RISK FACTORS; SURVIVORS; TELEPHONE;

EID: 33744988571     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000209447.63640.5a     Document Type: Article

References (51)

1. American Cancer Society. Cancer Facts and Figures. American Cancer Society: Atlanta, GA; 2005.
2. Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin's disease. JNCI. 1993;85:25-31.
3. 2a. Wolden SL, Hancock SL, Carlson RW, et al. Management of breast cancer after Hodgkin's disease. J Clin Oncol. 2000;18:765-772.
4. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386-4394.
5. van Leeuwen FE, Klockman WJ, Stovall M, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst. 2003;95:971-980.
6. Glanzmann C, Veraguth A, Lurolf UM. Incidence of second solid cancer in patients after treatment for Hodgkin's disease. Strahlenther Onkol. 1994;170:140-146.
7. Ng AK, Bernardo VP, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.
8. Yahalom J, Petrek JA, Biddinger PW, et al. Breast cancer in patients irradiated for Hodkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol. 1992;10:1674-1681.
9. Shapiro CL, Mauch PM. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective (editorial; comment). J Clin Oncol 1992;10:1662-1665.
10. Burke W, Daly M, Garber J, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA. 277;997-1003.
11. Bloom JR, Grazier K, Hayes WA, et al. Factors affecting the utilization of mammography among African American women. Epidemiol Biomarkers Prev. 1991;1:75-82.
12. Mandel JS, Bond JH, Church TR, et al. Reducing morbidity from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
13. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113:214-226.
14. Eddy DM, Hasselblad V, McGivney W, et al. The value of mammography screening in women under age 50 years. JAMA. 1988;259:1512-1519.
15. Bloom JR, Monterossa S. Hypertension labeling and sense of well-being. AJPH. 1982;71:1226-1232.
16. Haynes RB, Sackett DLO, Taylor DW, et al. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med. 1978;299:741-744.
17. Mossey JM. Psychosocial consequences of labeling in hypertension. Clin Invest Med. 1981;4:201-207.
18. Ellman R, Angeli N, Christian A, et al. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer. 1989;60:781-784.
19. Lerman C, Rimer B, Trock B, et al. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19:279-290.
20. Bloom JR, Cook M, Flamer DP, et al. Psychological response to mastectomy. Cancer January. 1987;59:189-196.
21. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. Mongr Natl Cancer Inst. 1994;16:171-175.
22. Lerman C, Trock B, Rimer B. Psychological side effects of breast cancer screening. Health Psychol. 1991;10:259-267.
23. Stefanek MC, Wilcox RN. First degree relatives of breast cancer patients: screening practices and provision of risk information. Cancer Detection Prevent. 1991;15:379-384.
24. Lerman C, Seay J. Balsham A, et al. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1994;57:385-392.
25. King ES, Rimer BK, Seay J, et al. Promoting mammography use through progressive interventions: is it effective? AJPH. 1994;106:104-106.
26. Rimer BK, Resch N, King E, et al. Multistrategy health education program to increase mammography use among women ages 65 and older. Pub Health Reports. 1992;107:369-380.
27. Miller SM, Siejak KK, Schroeder CM, et al. Enhancing adherence following abnormal pap smears among low-income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst. 1997;89:703-708.
28. Skipworth D. Telephone counseling interventions. J Psychosocial Nursing. 1994;32:7-12.
29. Bertera EM, Bertera RL. The cost-effectiveness of telephone vs. clinic counseling for hypertensive patients: a pilot study. AJPH. 1981;626-629.
30. Rosenstock IM. Historical origins of the Health Belief Model. Health Education Reports. 1974;2:328-335.
31. Levanthal H. Emotional and behavioral processes. In: Johnson J, Wallace L, eds. Stress and Medical Procedures. Oxford, England: Oxford Science and Medical Publications, 1989.
32. Levanthal H, Cameron L. Behavioral theories and the problem of compliance. Patient Ed Counsel. 1989;17-138.
33. Prochaska J, DiClemente CC. Transtheoretical therapy: toward an integrative model of change. Psychother Theory Res Practice. 1982;1:161-173.
34. Prochaska J, DiClemente CC. Stages and process of self-change in smoking: toward an integrative model. J Consult Clinical Psychol. 1983;51:390-395.
35. Prochaska J, DiClemente CC. The Transtheoretical Approach: Crossing Traditional Boundaries of Therapy. Chicago: Dow Jones/Irwin, 1984.
36. Rakowski W, Fulton JP, Feldman JP. Women's decision making about mammography: a replication of the relationship between stages of adoption and decisional balance. Health Psychol. 1993;12:209-214.
37. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Measurement. 1977;1:385-403.
38. Chamot E, Charvet AI, Perneger TV. Predicting stages of adoption of mammography screening in a general population. Eur J Cancer. 2001;37:1869-1877.
39. McCaul KD, Tulloch HE. Cancer screening decisions. Mongr Natl Cancer Inst. 1999;25:52-58.
40. Vernon SW. Risk perception and risk communication for cancer screening behavior: a review. Mongr National Cancer Inst. 1999;25:101-118.
41. Bloom JR, Stewart SL, Koo J, et al. Cancer screening in public health clinics: the importance of clinic utilization. Medical Care. 2001;39:1345-1351.
42. Zackrisson S, Andersson I, Manjer J, et al. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer. 2004;108:754-760.
43. Siapush M, Singh GK. Sociodemographic variations in breast cancer screening behavior among Australian women: results from the 1995 National Health Survey. Prev Med. 2003;35:174-180.
44. Lubish L, Greenberg S, Friger M, et al. Breast cancer screening in two multicultural family practice teaching clinics. Isr Med Assoc J. 2001;3:579-583.
45. Ulcickas Yood M, McCarthy BD, et al. Patterns and characteristics of repeat mammography among women 50 years and older. Cancer Epidemiol Biomarkers Prev. 1999;8:595-599.
46. Kurtz ME, Wyatt G, Kurtz JC. Psychological and sexual well-being, philosophical/spiritual views, and health habits of long-term cancer survivors. Health Care for Women International. 1995;16:253-262.
47. Isaacs C, Peshkin BN, Schwartz M, et al. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat. 2002;71:103-112.
48. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321-333.
49. Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465-475. Erratum in JAMA. 2003;290:1318.
50. Wrensch M, Chew T, Farren G, et al. Risk factors for breast cancer in a population with high incidence rates. Breast Cancer Res. 2003;5:R88-R102.
51. Rimer BK, Ross E, Balshem A, et al. The effect of a comprehensive breast screening program on self-reported mammography use by primary care physicians and women in a health maintenance organization. J Am Board Fam Pract. 1993;6:443-451.